Tinetti M E, Schmidt A, Baum J
Am J Med. 1986 May;80(5):844-8. doi: 10.1016/0002-9343(86)90626-1.
A decline in health status in a chronically ill, elderly patient could mean the progression of a known disease, depression, or the development of a new disease. The value of the erythrocyte sedimentation rate in selecting patients in whom the likelihood of a new disease is high enough to warrant a diagnostic evaluation was studied. Subjects included long-term residents of a chronic-care hospital over age 65 in whom the erythrocyte sedimentation rate was determined because of a nonspecific, subacute change in health status (n = 98) or new, unexplained musculoskeletal complaints (n = 44). The target erythrocyte sedimentation rate-elevating diseases included infections, connective tissue diseases, and malignancies. Among the group with subacute deterioration, post-test probabilities (incorporating clinical data with test results) of a new disease ranged from 7 percent in those with an erythrocyte sedimentation rate below 20 mm per hour to 66 percent in those with a rate of 50 mm per hour or more. The comparable probabilities among the group with musculoskeletal complaints were 3 percent and 57 percent. The erythrocyte sedimentation rate, an inexpensive test, although nonspecific, appears useful in deciding when to pursue expensive, and sometimes uncomfortable or hazardous, diagnostic evaluations. The erythrocyte sedimentation rate is most useful among patients in whom the probability of disease is moderate (neither very high nor very low) following initial history-taking and examination.
慢性病老年患者健康状况下降可能意味着已知疾病的进展、抑郁症或新疾病的发生。研究了红细胞沉降率在筛选新疾病可能性高到足以进行诊断评估的患者中的价值。研究对象包括一家慢性病医院65岁以上的长期住院患者,这些患者因健康状况出现非特异性亚急性变化(n = 98)或新发不明原因的肌肉骨骼症状(n = 44)而测定了红细胞沉降率。红细胞沉降率升高的目标疾病包括感染、结缔组织病和恶性肿瘤。在亚急性恶化组中,新疾病的检测后概率(结合临床数据和检测结果)在红细胞沉降率低于每小时20毫米的患者中为7%,在红细胞沉降率为每小时50毫米或更高的患者中为66%。有肌肉骨骼症状组的可比概率分别为3%和57%。红细胞沉降率检测价格低廉,虽然缺乏特异性,但在决定何时进行昂贵且有时不舒服或有风险的诊断评估时似乎很有用。在初次问诊和检查后疾病概率处于中等水平(既不非常高也不非常低)的患者中,红细胞沉降率最有用。